Autor: "Carlson, Jonathan M" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: CD8 T cells targeting adapted epitopes in chronic HIV infection promote dendritic cell maturation and CD4 T cell trans-infection.
Autorzy:: Qin K; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Boppana S; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Du VY; The Salk Institute for Biological Studies, La Jolla, California, United States of America.
Carlson JM; Microsoft Research, Redmond, Washington, United States of America.
Yue L; Emory Vaccine Center at Yerkes National Primate Research Center and Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, United States of America.
Dilernia DA; Emory Vaccine Center at Yerkes National Primate Research Center and Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, United States of America.
Hunter E; Emory Vaccine Center at Yerkes National Primate Research Center and Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, United States of America.
Mailliard RB; Department of Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
Mallal SA; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Bansal A; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Goepfert PA; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.; Pokaż więcej
Źródło:: PLoS pathogens [PLoS Pathog] 2019 Aug 09; Vol. 15 (8), pp. e1007970. Date of Electronic Publication: 2019 Aug 09 (Print Publication: 2019).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: CD4-Positive T-Lymphocytes/*immunology
CD8-Positive T-Lymphocytes/*immunology
Dendritic Cells/*immunology
Epitopes, T-Lymphocyte/*immunology
HIV Infections/*virology
HIV-1/*immunology
T-Lymphocytes, Cytotoxic/*immunology
Cross-Sectional Studies ; Female ; HIV Infections/immunology ; Humans ; Interferon-gamma/metabolism ; Longitudinal Studies ; Male ; Viral Load

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus.
Autorzy:: Tully DC; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Ogilvie CB; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Batorsky RE; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Bean DJ; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Power KA; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Ghebremichael M; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Bedard HE; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Gladden AD; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Seese AM; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Amero MA; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Lane K; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
McGrath G; Division of Infectious Disease, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Bazner SB; Division of Infectious Disease, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Tinsley J; The Fenway Institute, Fenway Health, Boston, Massachusetts, United States of America.
Lennon NJ; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.
Henn MR; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.
Brumme ZL; Faculty of Health Sciences, Simon Fraser University, Vancouver, British Columbia, Canada.
Norris PJ; Blood Systems Research Institute, San Francisco, California, United States of America.
Rosenberg ES; Division of Infectious Disease, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Mayer KH; The Fenway Institute, Fenway Health, Boston, Massachusetts, United States of America.
Jessen H; HIV Clinic Praxis, Jessen, Berlin, Germany.
Kosakovsky Pond SL; Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
Walker BD; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.; Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America.
Altfeld M; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.; Heinrich-Pette-Institut, Hamburg, Germany.
Carlson JM; Microsoft Research, Redmond, Washington, United States of America.
Allen TM; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.; Pokaż więcej
Źródło:: PLoS pathogens [PLoS Pathog] 2016 May 10; Vol. 12 (5), pp. e1005619. Date of Electronic Publication: 2016 May 10 (Print Publication: 2016).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:: HIV Infections/*transmission
HIV-1/*genetics
Evolution, Molecular ; Genetic Variation ; Genome, Viral ; HIV Envelope Protein gp120/genetics ; Humans ; Male ; Models, Theoretical ; Polymerase Chain Reaction ; Selection, Genetic/genetics

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa.
Autorzy:: Hölzemer A; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.; Heinrich-Pette-Institut, Leibniz Institute for Experimental Virology, Hamburg, Germany.; First Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Thobakgale CF; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, KwaZulu-Natal Research Institute for Tuberculosis and HIV, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Jimenez Cruz CA; Computational Biology Center, IBM Thomas J. Watson Research Center, Yorktown Heights, New York, United States of America.
Garcia-Beltran WF; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Carlson JM; Microsoft Research, Los Angeles, California, United States of America.
van Teijlingen NH; Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands.
Mann JK; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, KwaZulu-Natal Research Institute for Tuberculosis and HIV, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Jaggernath M; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, KwaZulu-Natal Research Institute for Tuberculosis and HIV, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Kang SG; Computational Biology Center, IBM Thomas J. Watson Research Center, Yorktown Heights, New York, United States of America.
Körner C; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.; Heinrich-Pette-Institut, Leibniz Institute for Experimental Virology, Hamburg, Germany.
Chung AW; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Schafer JL; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, United States of America.; Division of Microbiology, New England Primate Research Center, Southborough, Massachusetts, United States of America.
Evans DT; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, United States of America.; Division of Microbiology, New England Primate Research Center, Southborough, Massachusetts, United States of America.; Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Madison, Wisconsin, United States of America.
Alter G; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Walker BD; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Goulder PJ; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, KwaZulu-Natal Research Institute for Tuberculosis and HIV, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.; Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Carrington M; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.; Cancer and Inflammation Program, Laboratory of Experimental Immunology, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Hartmann P; First Department of Internal Medicine, Division of Infectious Diseases, University of Cologne, Cologne, Germany.; Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Cologne, Germany.
Pertel T; Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
Zhou R; Computational Biology Center, IBM Thomas J. Watson Research Center, Yorktown Heights, New York, United States of America.
Ndung'u T; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, KwaZulu-Natal Research Institute for Tuberculosis and HIV, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.; Max Planck Institute for Infection Biology, Berlin, Germany.; KwaZulu-Natal Research Institute for Tuberculosis and HIV, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Altfeld M; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.; Heinrich-Pette-Institut, Leibniz Institute for Experimental Virology, Hamburg, Germany.; Pokaż więcej
Źródło:: PLoS medicine [PLoS Med] 2015 Nov 17; Vol. 12 (11), pp. e1001900; discussion e1001900. Date of Electronic Publication: 2015 Nov 17 (Print Publication: 2015).
Typ publikacji:: Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Genetic Variation*
Immune Evasion*
HIV Core Protein p24/*genetics
HIV-1/*genetics
HLA-C Antigens/*genetics
Killer Cells, Natural/*immunology
gag Gene Products, Human Immunodeficiency Virus/*genetics
Cohort Studies ; Epitopes ; Female ; Genotype ; HIV Infections/immunology ; HIV-1/immunology ; HLA-C Antigens/immunology ; Humans ; Male ; RNA, Viral/genetics ; Receptors, KIR2DL3/immunology ; Reverse Transcriptase Polymerase Chain Reaction ; Sequence Analysis, RNA ; South Africa

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Prevalence and Characteristics of Hepatitis B Virus (HBV) Coinfection among HIV-Positive Women in South Africa and Botswana.
Autorzy:: Matthews PC; Nuffield Department of Medicine, University of Oxford, Peter Medawar Building for Pathogen Research, Oxford, United Kingdom; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Trust, John Radcliffe Hospital, Headington, Oxford, United Kingdom.
Beloukas A; Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Malik A; Department of Paediatrics, University of Oxford, Peter Medawar Building for Pathogen Research, Oxford, United Kingdom.
Carlson JM; Microsoft Research, eScience Group, Redmond, Washington, United States of America.
Jooste P; Paediatric Department, Kimberley Hospital, Kimberley, Northern Cape, South Africa.
Ogwu A; Botswana Harvard AIDS Institute Partnership, Botswana; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Shapiro R; Botswana Harvard AIDS Institute Partnership, Botswana; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Riddell L; Integrated Sexual Health Services, Northampton General Hospital, Cliftonville, Northampton, United Kingdom.
Chen F; Department of Sexual Health, Royal Berkshire Hospital, Reading, United Kingdom.
Luzzi G; Department of Sexual Health, High Wycombe Hospital, High Wycombe, Buckinghamshire, United Kingdom.
Jaggernath M; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Jesuthasan G; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Trust, John Radcliffe Hospital, Headington, Oxford, United Kingdom.
Jeffery K; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Trust, John Radcliffe Hospital, Headington, Oxford, United Kingdom.
Ndung'u T; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa; KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH), University of KwaZulu-Natal, Durban, South Africa; Max Planck Institute for Infection Biology, Chariteplatz, Berlin, Germany; The Ragon Institute of MGH, MIT and Harvard University, Cambridge, Massachusetts, United States of America.
Goulder PJ; Department of Paediatrics, University of Oxford, Peter Medawar Building for Pathogen Research, Oxford, United Kingdom; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Geretti AM; Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Klenerman P; Nuffield Department of Medicine, University of Oxford, Peter Medawar Building for Pathogen Research, Oxford, United Kingdom; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Trust, John Radcliffe Hospital, Headington, Oxford, United Kingdom; NIHR Biomedical Research Centre, John Radcliffe Hospital, Headley Way, Headington, Oxford, United Kingdom.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2015 Jul 28; Vol. 10 (7), pp. e0134037. Date of Electronic Publication: 2015 Jul 28 (Print Publication: 2015).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Coinfection/*epidemiology
HIV Infections/*epidemiology
HIV-1/*pathogenicity
Hepatitis B/*epidemiology
Hepatitis B virus/*pathogenicity
Adult ; Botswana/epidemiology ; Coinfection/complications ; Coinfection/virology ; Cross-Sectional Studies ; Female ; HIV Infections/complications ; HIV Infections/virology ; Hepatitis B/complications ; Hepatitis B/virology ; Humans ; Prevalence ; Retrospective Studies ; South Africa/epidemiology ; Viral Load

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial.
Autorzy:: Edlefsen PT; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Rolland M; US Military HIV Research Program, Silver Spring, Maryland, United States of America.
Hertz T; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; The Shraga Segal Dept. of Microbiology, Immunology and Genetics, Faculty of Health Sciences, and The National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Tovanabutra S; US Military HIV Research Program, Silver Spring, Maryland, United States of America.
Gartland AJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
deCamp AC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Magaret CA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Ahmed H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Gottardo R; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Juraska M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
McCoy C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Larsen BB; Department of Microbiology, University of Washington, Seattle, Washington, United States of America.
Sanders-Buell E; US Military HIV Research Program, Silver Spring, Maryland, United States of America.
Carrico C; Department of Biochemistry, University of Washington, Seattle, Washington, United States of America; IAVI Neutralizing Antibody Center and Department of Immunology and Microbial Sciences, The Scripps Research Institute, La Jolla, California, United States of America.
Menis S; Department of Biochemistry, University of Washington, Seattle, Washington, United States of America; IAVI Neutralizing Antibody Center and Department of Immunology and Microbial Sciences, The Scripps Research Institute, La Jolla, California, United States of America.
Kijak GH; US Military HIV Research Program, Silver Spring, Maryland, United States of America.
Bose M; US Military HIV Research Program, Silver Spring, Maryland, United States of America.
Arroyo MA; Royal Thai Army Component, AFRIMS, Bangkok, Thailand.
O'Connell RJ; US Army Component, AFRIMS, Bangkok, Thailand.
Nitayaphan S; Royal Thai Army Component, AFRIMS, Bangkok, Thailand.
Pitisuttithum P; Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Kaewkungwal J; Royal Thai Army Component, AFRIMS, Bangkok, Thailand.
Rerks-Ngarm S; CDC Department, Thai Ministry of Public Health, Nonthaburi, Thailand.
Robb ML; US Military HIV Research Program, Silver Spring, Maryland, United States of America.
Kirys T; Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, United States of America.
Georgiev IS; Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, United States of America.
Kwong PD; Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, United States of America.
Scheffler K; Department of Medicine, University of California, San Diego, La Jolla, California, United States of America.
Pond SL; Department of Medicine, University of California, San Diego, La Jolla, California, United States of America.
Carlson JM; eSience Research Group, Microsoft Research, Redmond, Washington, United States of America.
Michael NL; US Military HIV Research Program, Silver Spring, Maryland, United States of America.
Schief WR; Department of Biochemistry, University of Washington, Seattle, Washington, United States of America; IAVI Neutralizing Antibody Center and Department of Immunology and Microbial Sciences, The Scripps Research Institute, La Jolla, California, United States of America; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Mullins JI; Department of Microbiology, University of Washington, Seattle, Washington, United States of America.
Kim JH; US Military HIV Research Program, Silver Spring, Maryland, United States of America.
Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.; Pokaż więcej
Corporate Authors:: RV144 Sequencing Team
Źródło:: PLoS computational biology [PLoS Comput Biol] 2015 Feb 03; Vol. 11 (2), pp. e1003973. Date of Electronic Publication: 2015 Feb 03 (Print Publication: 2015).
Typ publikacji:: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:: AIDS Vaccines/*immunology
HIV Infections/*immunology
HIV Infections/*virology
HIV-1/*genetics
HIV-1/*immunology
Human Immunodeficiency Virus Proteins/*chemistry
AIDS Vaccines/genetics ; Binding Sites/genetics ; Genome, Viral/genetics ; HIV Infections/prevention & control ; Human Immunodeficiency Virus Proteins/genetics ; Humans ; Models, Molecular ; Molecular Sequence Data ; Sequence Alignment ; Sequence Analysis, Protein

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: CD8 and CD4 epitope predictions in RV144: no strong evidence of a T-cell driven sieve effect in HIV-1 breakthrough sequences from trial participants.
Autorzy:: Dommaraju K; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America; Henry Jackson Foundation, Bethesda, Maryland, United States of America.
Kijak G; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America; Henry Jackson Foundation, Bethesda, Maryland, United States of America.
Carlson JM; Microsoft Research, Los Angeles, California, United States of America.
Larsen BB; Department of Microbiology, University of Washington, Seattle, Washington, United States of America.
Tovanabutra S; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America; Henry Jackson Foundation, Bethesda, Maryland, United States of America.
Geraghty DE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Deng W; Department of Microbiology, University of Washington, Seattle, Washington, United States of America.
Maust BS; Department of Microbiology, University of Washington, Seattle, Washington, United States of America.
Edlefsen PT; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Sanders-Buell E; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America; Henry Jackson Foundation, Bethesda, Maryland, United States of America.
Ratto-Kim S; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America; Henry Jackson Foundation, Bethesda, Maryland, United States of America.
deSouza MS; Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Rerks-Ngarm S; Thai Ministry of Public Health, Nonthaburi, Thailand.
Nitayaphan S; Royal Thai Army Component, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Pitisuttihum P; Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Kaewkungwal J; Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
O'Connell RJ; Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Robb ML; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America; Henry Jackson Foundation, Bethesda, Maryland, United States of America.
Michael NL; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Mullins JI; Department of Microbiology, University of Washington, Seattle, Washington, United States of America.
Kim JH; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Rolland M; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America; Henry Jackson Foundation, Bethesda, Maryland, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2014 Oct 28; Vol. 9 (10), pp. e111334. Date of Electronic Publication: 2014 Oct 28 (Print Publication: 2014).
Typ publikacji:: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:: AIDS Vaccines/*therapeutic use
CD4-Positive T-Lymphocytes/*cytology
CD8-Positive T-Lymphocytes/*cytology
HIV Infections/*prevention & control
HIV-1/*genetics
Thioglycolates/*chemistry
Thiophenes/*chemistry
Adolescent ; Adult ; Alleles ; Epitopes, T-Lymphocyte/chemistry ; Female ; Genotype ; HIV Envelope Protein gp120/chemistry ; HLA Antigens/chemistry ; Humans ; Male ; Proteome/chemistry ; Young Adult ; gag Gene Products, Human Immunodeficiency Virus/chemistry

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Early immune adaptation in HIV-1 revealed by population-level approaches.
Autorzy:: Martin E
Carlson JM
Le AQ
Chopera DR
McGovern R
Rahman MA
Ng C
Jessen H
Kelleher AD
Markowitz M
Allen TM
Milloy MJ
Carrington M
Wainberg MA
Brumme ZL; Pokaż więcej
Źródło:: Retrovirology [Retrovirology] 2014 Aug 29; Vol. 11, pp. 64. Date of Electronic Publication: 2014 Aug 29.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Adaptation, Physiological*
Immune Evasion*
HIV Infections/*immunology
HIV-1/*immunology
Cross-Sectional Studies ; Histocompatibility Antigens Class I/genetics ; Humans ; gag Gene Products, Human Immunodeficiency Virus/genetics ; nef Gene Products, Human Immunodeficiency Virus/genetics

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: HIV transmission. Selection bias at the heterosexual HIV-1 transmission bottleneck.
Autorzy:: Carlson JM; Microsoft Research, Redmond, WA 98052, USA. carlson@microsoft.com .
Schaefer M; Emory Vaccine Center at Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Monaco DC; Emory Vaccine Center at Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Batorsky R; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02114, USA.
Claiborne DT; Emory Vaccine Center at Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Prince J; Emory Vaccine Center at Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Deymier MJ; Emory Vaccine Center at Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Ende ZS; Emory Vaccine Center at Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Klatt NR; Emory Vaccine Center at Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
DeZiel CE; Microsoft Research, Redmond, WA 98052, USA.
Lin TH; Microsoft Research, Redmond, WA 98052, USA.
Peng J; Microsoft Research, Redmond, WA 98052, USA.
Seese AM; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02114, USA.
Shapiro R; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Frater J; Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX1 7BN, UK. National Institute of Health Research, Oxford Biomedical Research Centre, Oxford OX3 7LE, UK. Oxford Martin School, University of Oxford, Oxford OX1 3BD, UK.
Ndung'u T; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02114, USA. HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban 4013, South Africa. KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban 4001, South Africa. Max Planck Institute for Infection Biology, D-10117 Berlin, Germany.
Tang J; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Goepfert P; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Gilmour J; International AIDS Vaccine Initiative, London SW10 9NH, UK. Imperial College of Science Technology and Medicine, London SW10 9NH, UK.
Price MA; International AIDS Vaccine Initiative, San Francisco, CA 94105, USA. Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA 94105, USA.
Kilembe W; Rwanda-Zambia HIV Research Group: Zambia-Emory HIV Research Project, Lusaka, Zambia.
Heckerman D; Microsoft Research, Los Angeles, CA 98117, USA.
Goulder PJ; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban 4013, South Africa. Department of Paediatrics, University of Oxford, Oxford OX1 3SY, UK.
Allen TM; Rwanda-Zambia HIV Research Group: Zambia-Emory HIV Research Project, Lusaka, Zambia. Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30322, USA. Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.
Allen S; International AIDS Vaccine Initiative, San Francisco, CA 94105, USA. Microsoft Research, Los Angeles, CA 98117, USA. Department of Paediatrics, University of Oxford, Oxford OX1 3SY, UK.
Hunter E; Emory Vaccine Center at Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA. Rwanda-Zambia HIV Research Group: Zambia-Emory HIV Research Project, Lusaka, Zambia. Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30322, USA. carlson@microsoft.com .; Pokaż więcej
Źródło:: Science (New York, N.Y.) [Science] 2014 Jul 11; Vol. 345 (6193), pp. 1254031. Date of Electronic Publication: 2014 Jul 10.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:: Heterosexuality*
Selection, Genetic*
HIV Infections/*transmission
HIV-1/*genetics
Amino Acid Sequence ; Consensus Sequence ; DNA Mutational Analysis ; Disease Transmission, Infectious/statistics & numerical data ; Female ; High-Throughput Nucleotide Sequencing ; Human Immunodeficiency Virus Proteins/genetics ; Humans ; Male ; Models, Statistical ; Molecular Sequence Data ; Point Mutation ; Risk Factors ; Viral Load

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Genotypic and functional impact of HIV-1 adaptation to its host population during the North American epidemic.
Autorzy:: Cotton LA; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
Kuang XT; Department of Molecular Biology and Biochemistry, Faculty of Science, Simon Fraser University, Burnaby, British Columbia, Canada.
Le AQ; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
Carlson JM; Microsoft Research, Los Angeles, California, United States of America.
Chan B; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
Chopera DR; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada; KwaZulu-Natal Research Institute for Tuberculosis and HIV, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.
Brumme CJ; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Markle TJ; Department of Molecular Biology and Biochemistry, Faculty of Science, Simon Fraser University, Burnaby, British Columbia, Canada.
Martin E; Department of Molecular Biology and Biochemistry, Faculty of Science, Simon Fraser University, Burnaby, British Columbia, Canada; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Shahid A; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
Anmole G; Department of Molecular Biology and Biochemistry, Faculty of Science, Simon Fraser University, Burnaby, British Columbia, Canada.
Mwimanzi P; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
Nassab P; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
Penney KA; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
Rahman MA; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
Milloy MJ; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Schechter MT; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Markowitz M; Aaron Diamond AIDS Research Center, The Rockefeller University, New York, New York, United States of America.
Carrington M; Cancer and Inflammation Program, Laboratory of Experimental Immunology, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America; Ragon Institute of MGH, MIT and Harvard University, Cambridge, Massachusetts, United States of America.
Walker BD; Ragon Institute of MGH, MIT and Harvard University, Cambridge, Massachusetts, United States of America.
Wagner T; San Francisco Department of Public Health, San Francisco, California, United States of America.
Buchbinder S; San Francisco Department of Public Health, San Francisco, California, United States of America.
Fuchs J; San Francisco Department of Public Health, San Francisco, California, United States of America.
Koblin B; New York Blood Center, New York, New York, United States of America.
Mayer KH; Fenway Community Health, Boston, Massachusetts, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America.
Harrigan PR; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Brockman MA; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada; Department of Molecular Biology and Biochemistry, Faculty of Science, Simon Fraser University, Burnaby, British Columbia, Canada; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Poon AF; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Brumme ZL; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.; Pokaż więcej
Źródło:: PLoS genetics [PLoS Genet] 2014 Apr 24; Vol. 10 (4), pp. e1004295. Date of Electronic Publication: 2014 Apr 24 (Print Publication: 2014).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Adaptation, Physiological/*genetics
HIV Infections/*genetics
HIV-1/*genetics
Amino Acid Sequence ; Genotype ; HLA Antigens/genetics ; Humans ; Male ; Molecular Sequence Data ; North America ; Phylogeny ; Polymorphism, Genetic/genetics